The Untold Truth On H. Pylori Recovery That My Doctor Intentionally didn't tell me!

My H. pylori Test Came Back Negative. Nobody Told Me Recovery Was a Separate Appointment.

By Claire Whitman

Health and science editor

By Claire Whitman / Health and science editor

Title

326,082 Views

The moment nobody warns you about is not the diagnosis. It is the follow-up.

It is a Tuesday afternoon, six weeks after your last antibiotic capsule. You are sitting across from the nurse practitioner. She clicks through your chart. She says the two words you have been waiting months to hear.

"You're negative."

You wait for the relief. It does not come.

You nod. You thank her. You ask the question you rehearsed in the parking lot. *Then why do I still feel like this?*

She shrugs, not unkindly. "Give it time. If the reflux keeps up, we can put you back on omeprazole."

You walk to the car. You sit in it for ten minutes without starting the engine. You look at the discharge paper in your lap. "Eradication confirmed. No further follow-up required." Four tidy words. Zero information about the burn under your ribs. Zero information about the food that still sits in your chest an hour after dinner. Zero information about the nine pounds you lost during your antibiotic course and have not gotten back. Zero information about the 4 a.m. anxiety you never had until this started.

You drive home. You put the paperwork in a drawer. A year later, you are still in the same body, reading something like this at midnight.

And the reason you are reading this at midnight is that you are not an edge case. You are a cohort.

H. pylori is the most common chronic bacterial infection in humans. Global estimates put lifetime exposure near half of the world's population. Recent U.S. data puts active infection at 18.2 percent of American adults, and lifetime exposure at 36.8 percent. If you have been treated for it, you are one of roughly 30 million Americans the healthcare system has quietly stopped tracking.

The number that should be on the evening news is the one that keeps turning up in the research and keeps not making it into the follow-up appointment:

Between 17 and 30 percent of successfully eradicated patients still report burning, reflux, or gastritis symptoms six months to five years after their final negative test.

On the low end, that is the population of Wyoming. On the high end, it is the population of Pennsylvania. Every year.

It is the Mayo Clinic Connect thread posted by a 19-year-old woman two years after her treatment: "My follow-up wasn't really in depth and didn't give me any information concerning H. pylori or any kind of expectations and care."

It is the forum user 11 months past her last antibiotic: "My doctor said I'm cured. I don't feel cured."

It is the patient on r/Hpylori who summarized the whole thing in one sentence: "The antibiotics killed the bug and my gut. I don't know which was worse."

Thirty million people. Reading the same sentences. Living in the same limbo. And the reason, once you see it, is not complicated.

What every patient in that 30-million cohort is actually living with is not leftover infection. It is a three-part aftermath that no antibiotic was designed to clean up.

The first part is inflammation that forgets to turn off. Years of bacterial colonization switched on a pro-inflammatory signaling system inside your stomach tissue. When the bacteria died, that system did not automatically reset. A cellular switchboard called Nrf2 (your body's built-in anti-inflammatory repair signal) stayed muted. The burning, the gnawing, the "every meal hurts" feeling you cannot point a doctor at is not the bacterium. It is the silence where the repair signal should be.

The second part is a microbiome that got cleared along with the target. A single course of clarithromycin plus amoxicillin can measurably disrupt the gut microbial community for four to eight years. Diversity plummets. Protective species collapse. The wrong species creep back in first. Which is why so many eradicated patients develop new reflux, new bloating, new IBS, new food sensitivities they never had before their treatment.

The third part is a proton pump that never got turned back on. The PPI you were given alongside the antibiotics was supposed to be temporary. Almost nobody tapers off. And when they try, they run into a trap we are going to come back to in a minute.

The H. pylori is gone. All three of those are still in the room.

Call the collision of those three things what it actually is.

The Eradication Gap. Your discharge paper closed the first chapter. The Eradication Gap is the chapter nobody wrote.

If that still feels abstract, here is the picture that makes it click.

Imagine you hired a demolition crew.

You had a decaying outbuilding on your property. Termites, rot, the works. The crew showed up in protective gear, leveled the structure in a long afternoon, and handed you a tidy invoice that read: Demolition: Complete.

That part worked. The building is gone.

What is also gone: the contents of the shed, a strip of turf the bulldozer tore up, a section of fence the workers bent, the flowerbed along the southern wall. The tires left ruts. The nail gun left a pile of shrapnel by the driveway.

The demolition was a success. Your yard is a disaster.

And the one thing the contractor never mentioned when he handed you the invoice is that he does not do rebuilds. That is an entirely different contract, with an entirely different crew, on an entirely different schedule. It is your problem to call someone about. Most homeowners never do, because they are staring at the sentence on the bottom of the invoice: Demolition Complete.

That sentence was true. It was also incomplete.

This is the gap you are standing in. Antibiotic triple therapy is a demolition crew. It is extremely good at its single job. It is not a rebuild. Nobody on staff at your GI's office is trained to run one. And until recently, nobody had a real post-eradication rebuild protocol to offer at all.

That piece has finally changed. Before we get to it, though, we have to come back to the trap I mentioned a moment ago: the one thing still keeping Aftermath Three welded into place for most people reading this.

CHECK AVAILABILITY

90-day money back guarantee

Reserve a Sproutly Pouch

Join community

Rated 1# Broccoli Sprout Supplement

Roughly 15 million Americans start every morning by swallowing a proton pump inhibitor. Prilosec. Nexium. Prevacid. Omeprazole.

A disproportionate slice of those 15 million were first handed the prescription during H. pylori treatment and have simply never been taken off.

Short term, during your antibiotic course, the PPI earned its place. It raised gastric pH so the antibiotics could actually reach the bacteria. The original FDA approval covered use up to 14 days.

The average post-eradication patient stays on it for more than three years.

Long-term PPI use has been associated, in large peer-reviewed observational cohorts, with measurably higher rates of chronic kidney disease (JAMA Internal Medicine, 2016), dementia (JAMA Neurology, 2016), bone fractures (the FDA added a fracture warning to the label in 2010), and severe deficiencies in B12, magnesium, calcium, iron, and zinc.

There is a reason for that last one. The same acid the drug suppresses is the acid your body uses to absorb those nutrients. It is also the acid that keeps your gut microbes in their lanes. It is also the acid whose rhythmic signals tell your stomach lining to renew itself every few days.

Quiet the acid long enough, and you quiet the renewal.

Then there is the exit ramp nobody tells you about. The day you stop a PPI you have been on for months, your acid pumps come back online at a higher level than baseline. The research calls it rebound acid hypersecretion. One landmark trial put healthy, previously-asymptomatic volunteers on an eight-week PPI course.

When they stopped, 44% of them developed new heartburn, reflux, or dyspepsia within two months. The placebo arm saw 15%.

If you are a post-H. pylori patient, that rebound feels exactly like your infection coming back. It isn't. It is the medication leaving. And because it feels like relapse, most patients reach for the bottle, refill the prescription, and quietly lock the cycle in for another year.

None of this is an argument to stop your PPI today. It is an argument to have a specific conversation with the doctor who prescribed it. (A conversation a growing number of gastroenterologists are now initiating on their own, under the clinical header "safe deprescribing of chronic PPI therapy where appropriate.")

You were not supposed to be on a 14-day drug for three years. You are not imagining the trap. You are standing inside it.

And once you have started to suspect the PPI loop, you usually end up in the same next place almost every post-eradication patient ends up.

Every post-eradication patient who figures out the PPI loop ends up in the supplement drawer.

If you have been there long enough, your medicine cabinet has an entire shelf that used to belong to a simpler life. DGL licorice. Slippery elm. Marshmallow root. Mastic gum. Zinc carnosine. L-glutamine. Apple cider vinegar. Manuka honey. Three different probiotic brands, all opened, none finished. A digestive enzyme from the refrigerator door. An elimination-diet printout on the fridge.

Some of that gave you a week of relief. A couple gave you a month. None held.

And there is a reason none of it held.

Every cell in your stomach has a repair system that predates every pharmacy in human history. It has a formal name (the Keap1-Nrf2 pathway) and an informal one: your body's internal maintenance department. When it fires, it activates more than 200 genes that quiet inflammation, rebuild the lining, and restore the microscopic barrier between acid and tissue. It is the same system that lets a paper cut seal itself in three days.

During a chronic H. pylori infection, that department is gradually understaffed. During antibiotic therapy, it takes another hit. By the time your breath test comes back negative, the maintenance department has been operating on skeleton crew for years.

The shelf full of slippery elm and aloe juice you bought gave your lining a soft cushion to sit on. It did not turn the department back on. Because none of it does.

For thirty years, scientists have been trying to identify the one natural compound on earth that flips the Nrf2 switch back on the hardest.

The answer is not what anyone expected, and it is where every one of those 30 million stories starts to turn.

In 1992, a pharmacologist at Johns Hopkins named Paul Talalay published a paper in Proceedings of the National Academy of Sciences that ended up on the front page of the New York Times. He had isolated a compound in cruciferous vegetables that activated the Keap1-Nrf2 pathway more powerfully than anything his lab had ever tested. He named it sulforaphane.

Two years later, his mentee Dr. Jed Fahey made the finding that changed the practical picture. Three-day-old broccoli microgreens contain 20 to 50 times more of the sulforaphane precursor than mature broccoli. A handful of seedlings outperformed a full head of broccoli by an entire order of magnitude.

For most people this would have stayed an interesting antioxidant story. For post-H. pylori patients, it became something far more specific.

In 2002, Fahey and colleagues published in PNAS that sulforaphane inhibited every tested strain of Helicobacter pylori in laboratory cultures, including strains resistant to clarithromycin.

In 2009, Yanaka, Fahey, and colleagues published the landmark human trial in Cancer Prevention Research. Forty-eight H. pylori-infected patients ate broccoli microgreens daily for eight weeks. The sprout group saw a greater-than-40-percent reduction in H. pylori stool antigen and measurable drops in gastric inflammation markers. The placebo arm saw nothing. When the sprouts stopped, the effect reversed.

Which means the same compound that flips the Nrf2 switch back on is the compound that quiets H. pylori-driven inflammation in human stomach tissue. One compound. Both jobs. Exactly the thing the Eradication Gap has been waiting for.

Which makes the obvious first thought: fine, I'll just eat the microgreens.

Except you cannot.

Check Research Report

To hit the dose the research uses, you would need to eat three to four pounds of fresh microgreens every day.

Every single day.

Microgreens are expensive in that quantity. They rot fast. They taste like wet grass. The glucoraphanin (the raw ingredient you want) begins degrading within 48 hours of harvest, which means the plastic clamshell at your grocery store has usually lost most of its potency before you got it home.

And there is a catch that matters more for someone in your specific situation. Your gut, after antibiotic therapy, is worse at making the sulforaphane conversion on its own than an uninfected person's gut. The bacteria that normally help were collateral damage in the eradication protocol. Eating more microgreens into a depleted gut is like pouring gasoline into a car with a cracked fuel line.

Which is exactly why broccoli sprout capsules exist in the first place. Concentrate the compound. Take two pills. Skip the kitchen. A fine idea.

And the reason the vast majority of them are a quiet failure is in a single piece of chemistry almost nobody explains to you.

Sulforaphane is not an ingredient you can put in a capsule. It is the product of a chemical reaction between two things.

Glucoraphanin. The raw precursor. Shelf-stable. Easy to put in a pill.

Myrosinase. The enzyme that turns glucoraphanin into sulforaphane. Fragile. Heat-sensitive. Acid-sensitive. Ruined by most manufacturing processes.

Both pieces live in a fresh microgreen, separated by a cell wall. When you chew the sprout, the wall ruptures, the two meet, and sulforaphane forms right there on the plate.

The supplement industry solved the first half of that equation a decade ago. Almost nobody bothered to solve the second half. The reason is not a mystery. Myrosinase is harder to protect, more expensive to source, and impossible to fake on a label. The industry learned quickly that consumers do not know the enzyme is supposed to be there.

So the bottles get made anyway. Glucoraphanin in. No active myrosinase. The label still says "broccoli sprout extract." The price still sits between $30 and $80. You take it for six weeks. Nothing happens. You conclude, honestly and wrongly, that sulforaphane does not work for you.

It did not fail to work for you. It never actually formed.

The raw ingredient sat in your stomach. The reaction partner was missing. Which is what every patient before you is quietly experiencing when they tell their friends that "the broccoli thing didn't do anything."

And that naturally raises the one question every reader has by the time they get here.

If the post-H. pylori sulforaphane research is this well-documented and the missing-enzyme problem is this obvious once someone points at it, why is none of this coming up in your follow-up appointments?

Three reasons. None of them conspiratorial.

The first is that supplement companies compete on price per bottle, not on completeness of formula. A glucoraphanin-only capsule costs a few cents to make. A formula that includes the active enzyme plus a backup enzyme source costs several times that. The cheaper version has outsold the real thing for a decade, because consumers cannot see the difference on a label.

The second is that American gastroenterology is optimized for acute interventions, not slow cellular rebuilds. Your fifteen-minute follow-up has almost no room for a protocol whose effects play out over eight to twelve weeks. A PPI refill fits the appointment. A mucosal-repair protocol does not. Over time, every clinic bends toward what fits the appointment.

The third is that broccoli sprouts cannot be patented. A compound from a three-day-old seedling has no intellectual-property moat. No pharmaceutical sales rep walks into a GI's office with a glossy binder about sulforaphane. The research stays in the papers. The papers stay unread.

Three decades of research. No drug rep in the waiting room. A discharge paper that says Eradication Complete. A patient still scrolling articles at midnight.

Which is exactly the space someone had to build a product for.

This is the whole reason Sproutly exists.

Exclusive Offer Ends

00

HRS

00

MIN

00

SEC

2,500+ Verified Reviews!

Rebuild your stomach lining with broccoli sprouts

CHECK AVAILABILITY →

Try it today with a 90-Day Money Back Guarantee!

The question that drove the entire formulation was narrow: what would it take to deliver the dose of active sulforaphane the research actually uses, into a gut that just finished antibiotic therapy, in two capsules you can swallow with your morning coffee?

The answer is a three-part system, in the proportions the peer-reviewed work points to.

700 mg of broccoli seed extract, standardized to 13 percent glucoraphanin. The concentrated precursor. A wheelbarrow of microgreens, packed into a daily dose.

200 mg of broccoli sprout extract carrying active, protected myrosinase. The enzyme that makes the reaction actually happen inside you. The piece the rest of the category leaves out.

100 mg of mustard seed extract. A second, structurally different source of the same enzyme. An intentional redundancy, because a post-antibiotic stomach is unpredictable. If acid compromises the first enzyme, the second one steps in.

Plus 50 mg of Vitamin C as the cofactor for tissue repair and Nrf2 signaling.

Two capsules. Once a day. With breakfast.

Every milligram is printed on the label. No proprietary blends. No fillers. Manufactured in an FDA-registered facility. Independently lab-tested for heavy metals, potency, and purity. Non-GMO. Vegan. GMP certified.

It is not a cure. It is not a detox. It is not a replacement for medical care.

It is a daily post-eradication support protocol. A full dose. The active enzyme. A backup key when the first one gets tired. The rebuild contract your discharge paper never signed.

You are probably wondering how long will this take to heal my stomach lining.

Here is what the research and thousands of customer reports suggest the next 90 days look like. Your body is your own. Your timeline will be too.

Weeks 1 and 2. Nothing dramatic on the outside. This is where most people get impatient. Inside, your Nrf2 pathway is registering its first real activation signal in months or years. The maintenance department is clocking back in. You will not feel this yet. It is happening anyway.

Weeks 3 and 4. The burning starts to space out. The knot under the ribs loosens. The moment most customers remember is small. A meal they used to brace for (coffee, tomato sauce, spicy takeout) that did not cost them later. One 90-day participant wrote, "I realized on a Tuesday that I hadn't thought about my stomach all morning."

Weeks 5 through 8. This is the exact window the 2009 Yanaka trial directly measures. Markers of gastric inflammation drop meaningfully inside this window in the published data. Sleep returns. Food sensitivities soften. The baseline of "how I feel at rest" resets upward.

Weeks 9 through 12. Meals stop being a calculation. You notice, sometimes with a jolt, that you have not carried antacids in your bag for a week. Friends at dinner order from the wine list without you doing the math. For many post-eradication patients, this is the first time since their treatment that they stop thinking of themselves as recovering from H. pylori and start thinking of themselves as simply done with it.

Which is where every post-H. pylori story eventually reaches the same quiet fork.

The Sproutly Promise

Try It Risk-Free for 90 Days

Take Sproutly for ninety full days.

Not thirty. Not sixty. Ninety.

That is the window the 2009 post-H. pylori clinical trial actually measured. Anything shorter is not a fair test of your own body.

Take it every morning. Pay attention to the small things. The meals you brace for and do not have to. The nights you sleep flat without thinking about it. The antacids you keep forgetting to carry.

If after ninety days you cannot point to a clear, meaningful difference, mail back whatever you have left. Full pouch, empty pouch, half-empty pouch. Every dollar comes back to your card. No restocking fee. No "processing fee." No cancellation script.

We offer the ninety-day guarantee because the research gave us a ninety-day window to prove out a hypothesis. If the hypothesis fails in your body, you should not be paying for it. That is the entire logic of the promise.

Exclusive Offer Ends

00

HRS

00

MIN

00

SEC

2,500+ Verified Reviews!

The rebuild protocol for a gut that already finished its antibiotics.

View current availability here →

Try it today with a 90-Day Money Back Guarantee!

LIMITED AVAILABILITY NOTICE ⚠️

To ensure quality and freshness, Sproutly is produced in small batches.

Availability may be limited based on current demand.

👉 View current availability here

Jessica T.

Breath test was negative fourteen months ago and nobody explained why I still could not eat a normal lunch. Started Sproutly in January. Eight weeks in I realized I had not checked the omeprazole bottle in four days. I went a whole weekend without it. Then a week. My doctor signed off on a taper after I showed her my notes. That is a sentence I did not think I would get to write in 2026.

9

Marco R.

I did everything right. Finished the antibiotics. Got the clean scope. My life was plain chicken and rice twice a day because every other food hurt. My wife ordered me Sproutly after reading a research paper on sulforaphane. I was the skeptic. By the end of week seven I had eaten pizza twice and slept flat both nights. The biochemistry explanation is what sold me. The dinner is what convinced me.

Pauline

ICU nurse, twenty years in. I was treated for H. pylori in 2023. I spent the next year telling patients "give it time" while my own stomach kept burning. The myrosinase argument is what made me try this. It is the first supplement I have been willing to recommend to family. Ninety days in I am sleeping flat for the first time since the antibiotics. I do not know how else to put it.

2

Darnell

The drawer of half-opened gut supplements is real. DGL, zinc carnosine, mastic gum, slippery elm, three probiotics. Some helped a little. None held. The difference here was that around week six I realized I had stopped scanning my chest after every meal. Stopped bracing. You stop noticing. That is the part people do not describe right. The improvement is not loud. You just stop noticing.

Eleanor B.

Post-eradication almost three years. I had decided the stomach I had was the stomach I was going to have. I was wrong. I was wrong about a lot of things. Started Sproutly in September. Week ten I ate dinner at my daughter's birthday without doing the usual math first. Thank you to whoever fought for the mustard seed line on the label

Check out more reviews →

References

Talalay P, Fahey JW, et al. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proceedings of the National Academy of Sciences (1997).
Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, Talalay P, Lozniewski A. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. PNAS (2002).
Yanaka A, Fahey JW, Fukumoto A, et al. Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prevention Research (2009).
Hooi JKY, Lai WY, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology (2017).
Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology (2009).
Lazarus B, Chen Y, Wilson FP, et al. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Internal Medicine (2016).
Gomm W, von Holt K, Thomé F, et al. Association of Proton Pump Inhibitors With Risk of Dementia. JAMA Neurology (2016).
Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science (2016).

Privacy & Cookie Disclosure

We may collect limited personal information for marketing and communication purposes. Any information collected is used to improve user experience and will only be collected with clear notice. This website uses cookies for marketing and analytics purposes.

Advertising Disclosure

This website is an advertisement and not a news article, blog, or consumer protection update. The content on this page is for promotional purposes, and the owners of this website receive compensation from the sale of Sproutly products.

Marketing & Affiliate Disclosure

This website may receive compensation when users purchase products through links on this page. This compensation helps support the operation of this site. Any compensation received does not influence the information presented, which is based on product features and publicly available research.

Additional Disclosure

This website is not a news publication. Any individuals shown in images or videos are models and are used for illustrative purposes only. Statements on this site have not been evaluated by the FDA. This site exists to provide information and direct consumers to products they may choose to purchase.

Title